Your browser doesn't support javascript.
loading
Conditional power and information fraction calculations at an interim analysis for random coefficient models.
Lewis, Sandra A; Carroll, Kevin J; DeVries, Todd; Barratt, Jonathan.
Afiliação
  • Lewis SA; Chinook Therapeutics, Novartis Company, Seattle, Washington, USA.
  • Carroll KJ; KJC Statistics Ltd, Cheadle Hulme, Cheadle, UK.
  • DeVries T; Chinook Therapeutics, Novartis Company, Seattle, Washington, USA.
  • Barratt J; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
Pharm Stat ; 23(2): 276-283, 2024.
Article em En | MEDLINE | ID: mdl-37919258
ABSTRACT
Random coefficient (RC) models are commonly used in clinical trials to estimate the rate of change over time in longitudinal data. Trials utilizing a surrogate endpoint for accelerated approval with a confirmatory longitudinal endpoint to show clinical benefit is a strategy implemented across various therapeutic areas, including immunoglobulin A nephropathy. Understanding conditional power (CP) and information fraction calculations of RC models may help in the design of clinical trials as well as provide support for the confirmatory endpoint at the time of accelerated approval. This paper provides calculation methods, with practical examples, for determining CP at an interim analysis for a RC model with longitudinal data, such as estimated glomerular filtration rate (eGFR) assessments to measure rate of change in eGFR slope.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Limite: Humans Idioma: En Revista: Pharm Stat Assunto da revista: FARMACOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Limite: Humans Idioma: En Revista: Pharm Stat Assunto da revista: FARMACOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos